🇺🇸 FDA
Patent

US 7981864

Methods and compositions for targeting proteins across the blood brain barrier

granted A61KA61K38/30

Quick answer

US patent 7981864 (Methods and compositions for targeting proteins across the blood brain barrier) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/30